Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study: Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib (TACTICS)

NCT01217034 is registered in ClinicalTrials.gov with Kindai University as lead sponsor.

NCT NCT01217034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01217034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study: Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib (TACTICS)
Lead sponsor
Kindai University
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2010
Completion date
March 31, 2018
Enrollment
228 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular, hepatocellular carcinoma, liver neoplasm, unresectable hepatocellular carcinoma